Reversal of Fortune<br />By Rev Shark<br />RealMoney.com Contributor<br />7/16/2009 8:26 AM EDT <br /><br />Nothing is more dangerous to men than a sudden change of fortune. <br />-- Marcus Fabius Quintilian<br /><br />A very well-defined and -recognized technical pattern known as a head-and-shoulders top turned into a massive bear trap that was sprung by a much-better-than-anticipated earnings report from Intel (INTC) . The market leapt forward on the Intel news and only dipped briefly for a couple minutes right before the final bell. <br /><br />Particularly noteworthy about the action is that it wasn't just semiconductors or technology that ran higher on the Intel news -- it was the whole market. From Coke (KO) to American Express (AXP) to Exxon Mobil (XOM) , every major sector was sharply higher. Breadth was very strong and volume very heavy. <br /><br />Action that strong deserves respect, and even though the market was looking like it was ready to fall into the hole just a week ago, we can't easily dismiss such strong action. There are a lot of good fundamental arguments against this market moving higher, but the technical and price action has to be given some respect. <br /><br />What makes things even more difficult is that we probably have the most important group of earnings report for the quarter being released after the close tonight. This evening we have reports from Google (GOOG) and IBM (IBM) , and then in the morning we have GE (GE) and Citigroup (C) . <br /><br />The Intel report and subsequent market response changes expectations, much like the Meredith Whitney upgrade of Goldman Sachs (GS) on Monday changed expectations for that stock. If Intel is good, then IBM and Google should be pretty good as well, but after the big bump up on Wednesday, how good do they have to be in order to keep moving upward? <br /><br />Although I was offline for several hours yesterday due to a power outage, I was surprised at what seemed to me to be a relatively sedate reaction to the huge move. Usually you'd see the folks on CNBC tripping over themselves with glee and plenty of perma-bulls thumping themselves in self-congratulations. I suspect that the cool celebration was due to the fact that so many folks were caught by surprise. That is probably confirmed by the way the market didn't dip for more than a few minutes all day. Folks were scrambling to gain some long exposure, and they were so impatient they wouldn't even wait for a pullback. <br /><br />So now what? First, as noted, we have to give the very positive technical action some respect. It would be foolish to anticipate a quick reversal given so much strength. On the other hand, with big earnings reports coming tonight and expectations increased so much, it is going to be difficult to keep this pace going. It'll be much easier to disappoint this market now with a report that isn't as upbeat as Intel's or Goldman's. <br /><br />My game plan is to see if I can catch a little more upside momentum in some individual stocks but to watch for an opportunity for a quick index short. I do not like to place bets on earnings reports, so that means I'm not going to be holding much overnight. I'll reassess after we have the news tomorrow morning, but it is going to be tricky navigating through news reports in an environment where expectations change so dramatically and so quickly. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: CVBF +9.9%, UFPI +8.2% (light volume), BIIB +5.0%, PLCM +3.9% (also upgraded to Buy at Brean Murray; tgt $29), NVS +2.6%... M&A news: MOS +10.0% (seeing early strength with Bloomberg citing Estado reports that VALE considers $25 bln bid for MOS)... Select ag/chem names showing strength following MOS bid reports: IPI +4.2%, POT +2.6%, CF +1.5%, MON +1.5%, TRA +1.1%... Select financials ticking higher: ING +5.1%, HBC +1.7%, AXA +1.2%... Other news: BFRM +15.2% (announces FDA approval for mixing lidocaine with Radiesse dermal filler), BUCY +6.1% (On CNBC yesterday Dennis Gartman said he thought he'd be a buyer of BUCY Thursday morning), SNDK +4.9% (Cramer makes positive comments on MadMoney; ests raised at Lazard Capital Mkts on strong 2Q finish), JOYG +2.7% (up in sympathy with BUCY), ELN +2.6% (up in sympathy with BIIB), SNY +1.9% (Sanofi-Aventis gets French govt order to make A/H1N1 vaccine - DJ)... Analyst comments: JRCC +6.3% (upgraded to Buy from Neutral at UBS), PCX +4.2% (upgraded to Buy from Neutral at UBS), STLD +1.7% (hearing added to Buy List at tier 1 firm). <br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: JOEZ -13.6% (light volume), NOK -11.9%, MTG -11.2%, RECN -8.1%, XLNX -6.5%, MAR -6.1%, APH -5.7%, HOG -4.8%, CTAS -4.6%, LSTR -3.4% (also raises quarterly dividend 13% to $0.045 per share), FCS -3.3%, NXY -2.8% (light volume), KMP -1.4%, JPM -0.9%... M&A news: VALE -1.4% (ticking lower following reports that the co considers bid for MOS)... Other news: TRGT -9.9% (modestly pulling back after yesterday's 80%+ surge higher), SLT -8.0% (prices 123,456,790 ADSs at $12.15/ADS), SENEA -6.5% (prices approx 3.27 mln common share offering at $22.00/share), RFMD -5.1% (still checking), AIXG -4.7% (still checking), CELL -3.8% (prices 15.0 mln common shares by NC Telecom Holding at $5.00/share), AIG -1.9% (American Intl AIG to accelerate separation of ALICO; co seek an initial public offering and public listing)... Analyst comments: MOT -4.7% (cut to Neutral from Buy at Goldman- Reuters), MEDX -4.2% (downgraded to Neutral from Buy at UBS).